Sotera Health (NASDAQ:SHC) Shares Sold by Sanctuary Advisors LLC

Sanctuary Advisors LLC decreased its holdings in shares of Sotera Health (NASDAQ:SHC) by 50.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,274 shares of the company’s stock after selling 14,814 shares during the quarter. Sanctuary Advisors LLC’s holdings in Sotera Health were worth $199,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Blue Trust Inc. grew its position in Sotera Health by 164.3% in the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock valued at $25,000 after acquiring an additional 1,140 shares in the last quarter. True Wealth Design LLC purchased a new position in shares of Sotera Health in the third quarter valued at $32,000. GAMMA Investing LLC grew its holdings in Sotera Health by 37.5% during the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock valued at $56,000 after purchasing an additional 1,121 shares in the last quarter. Capital Performance Advisors LLP purchased a new stake in Sotera Health during the 3rd quarter worth $91,000. Finally, Oak Thistle LLC acquired a new position in Sotera Health in the 4th quarter worth $222,000. 91.03% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

SHC has been the subject of several recent analyst reports. Citigroup raised their target price on Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, November 6th. Barclays lowered their price objective on Sotera Health from $17.00 to $16.00 and set an “overweight” rating for the company in a research note on Friday, February 28th. Royal Bank of Canada restated an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a report on Thursday, November 21st. Finally, The Goldman Sachs Group began coverage on Sotera Health in a research note on Friday, December 6th. They set a “neutral” rating and a $14.00 target price for the company. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, Sotera Health has an average rating of “Moderate Buy” and an average price target of $15.92.

Sotera Health Stock Up 3.1 %

Shares of Sotera Health stock opened at $11.82 on Thursday. The business has a 50-day moving average price of $13.34 and a 200 day moving average price of $14.44. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $17.08. The firm has a market cap of $3.35 billion, a P/E ratio of 47.28 and a beta of 1.91. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.